Human Reproduction, Vol 13, 1837-1840, Copyright © 1998 by Oxford University Press
L Pal, L Leykin, JL Schifren, KB Isaacson, YC Chang, N Nikruil, Z Chen and TL Toth
A case series of eight cycles of in-vitro fertilization (IVF) in five women
diagnosed with malignant disorders is presented. These patients chose to
defer definitive treatment for a chance for preservation of potential
fertility. The response of these patients to ovarian stimulation, and the
outcome, was compared with 17 IVF cycles in 12 age- matched patients with
isolated tubal infertility. An apparent adverse influence of malignant
disease on the quality and behaviour of oocytes was observed. Despite a
comparable total number of oocytes per cycle in the two groups, a
significantly reduced percentage of mature oocytes was retrieved per cycle
from patients with malignant diseases. The oocytes from patients with
malignant disorders were of a poorer quality and exhibited a significantly
impaired fertilization rate compared to the controls. We propose that
neoplastic processes, irrespective of the site or cell of origin, may have
a detrimental impact on the biology of oocytes, an effect akin to that seen
on spermatozoa in men with certain malignancies.
ARTICLES
Malignancy may adversely influence the quality and behaviour of oocytes
Department of Reproductive Endocrinology and Infertility, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Revel and J. Schenker Ovarian tissue banking for cancer patients: is ovarian cortex cryopreservation presently justified? Hum. Reprod., January 1, 2004; 19(1): 14 - 19. [Abstract] [Full Text] [PDF] |
||||
